Comparison between Alkem Laboratories IPO and Dr.Lal PathLabs IPO.
Alkem Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Dr.Lal PathLabs IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Alkem Laboratories IPO is up to ₹1,347.76 Cr whereas the issue size of the Dr.Lal PathLabs IPO is up to ₹631.91 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of Dr.Lal PathLabs IPO is ₹550.00 per share.
| Alkem Laboratories IPO | Dr.Lal PathLabs IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,020.00 per share | ₹540.00 per share |
| Issue Price (Upper) | ₹1,050.00 per share | ₹550.00 per share |
| Issue Price (Final) | ₹1,050.00 per share | ₹550.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹15.00 per share |
| Discount (Employee) | ₹100.00 per share | |
| Market Lot Size | 14 shares | 20 shares |
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,28,53,442 shares | 1,16,00,000 shares |
| OFS Issue Size (Amount) | up to ₹1,347.76 Cr | up to ₹631.91 Cr |
| Issue Size Total | 1,28,53,442 shares | 1,16,00,000 shares |
| Issue Size Total (Amount) | up to ₹1,347.76 Cr | up to ₹631.91 Cr |
Alkem Laboratories IPO opens on Dec 08, 2015, while Dr.Lal PathLabs IPO opens on Dec 08, 2015. The closing date of Alkem Laboratories IPO and Dr.Lal PathLabs IPO is Dec 10, 2015, and Dec 10, 2015, respectively.
| Alkem Laboratories IPO | Dr.Lal PathLabs IPO | |
|---|---|---|
| Anchor Bid Date | Dec 07, 2015 | Dec 07, 2015 |
| Issue Open | Dec 08, 2015 | Dec 08, 2015 |
| Issue Close | Dec 10, 2015 | Dec 10, 2015 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 23, 2015 | Dec 23, 2015 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Alkem Laboratories IPO P/E ratio is , as compared to Dr.Lal PathLabs IPO P/E ratio of .
| Alkem Laboratories IPO | Dr.Lal PathLabs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 70.87 | 63.67 | ||||
| Promoter Shareholding (Post-Issue) | 66.23 | 58.7 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹12554.33 Cr. | ₹4545.46 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 15.4% | 27.85% |
In the Alkem Laboratories IPO Retail Individual Investors (RII) are offered 43,94,086 shares while in Dr.Lal PathLabs IPO retail investors are offered 43,94,086 shares. Qualified Institutional Buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 23,20,000 shares in Dr.Lal PathLabs IPO.
| Alkem Laboratories IPO | Dr.Lal PathLabs IPO | |
|---|---|---|
| Anchor Investor Reservation | 37,66,358 shares | 34,80,000 shares |
| Market Maker Reservation | ||
| QIB | 25,10,906 shares | 23,20,000 shares |
| NII | 18,83,179 shares | 17,40,000 shares |
| RII | 43,94,086 shares | 40,60,000 shares |
| Employee | 2,98,913 shares | |
| Others | ||
| Total | 1,28,53,442 shares | 1,16,00,000 shares |
Alkem Laboratories IPO subscribed 44.29x in total, whereas Dr.Lal PathLabs IPO subscribed 33.41x.
| Alkem Laboratories IPO | Dr.Lal PathLabs IPO | |
|---|---|---|
| QIB (times) | 57.19x | 63.56x |
| NII (times) | 129.96x | 61.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.17x | 4.24x |
| Employee (times) | 0.67x | |
| Other (times) | ||
| Total (times) | 44.29x | 33.41x |
